BURLINGAME, CA, UNITED STATES, February 5, 2025 /EINPresswire / -- The Pen Needles Market Report is the result of extensive research and analysis conducted by our team of experienced market ...

The company's blockbuster semaglutide drugs, Wegovy for weight loss and Ozempic for diabetes ... Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy are shown in this photo ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling ... latest numbers can move the needle in a competitive market.

Ozempic and Rybelsus are marketed by Novo Nordisk for treatment of type 2 diabetes, while Wegovy is marketed for weight loss. Ozempic and Wegovy are both weekly injections. Ozempic is sold in ...

Ozempic and Wegovy come in special injector pens that make it easy to get the dosing right. But the company that makes those drugs, Novo Nordisk, has the exclusive right to make those injector pens.